Ceylon Cinnamon for Blood Sugar: Small Effect, Big Marketing
Cinnamon has been one of the most popular supplements for blood sugar control for 15 years. The evidence for a real glucose-lowering effect is consistent but small; the effect size is routinely exaggerated in marketing; and the choice between Ceylon and cassia cinnamon matters for safety at daily doses.
The Meta-Analysis
A 2019 systematic review in Diabetic Medicine analysed 18 RCTs of cinnamon in type 2 diabetes and prediabetes. Cinnamon reduced fasting glucose by ~5–10 mg/dL and HbA1c by ~0.2 percentage points on average. These are real but modest effects — a fraction of what metformin produces, and comparable to what dietary fibre or basic exercise achieves.
Ceylon vs Cassia
Cassia cinnamon (Cinnamomum cassia, common supermarket cinnamon) is high in coumarin — a natural compound with hepatotoxic and mild anticoagulant effects. The European Food Safety Authority sets a tolerable daily coumarin intake of 0.1 mg/kg body weight. Regular cassia cinnamon at 1 teaspoon/day can exceed this for a small adult. Ceylon cinnamon (Cinnamomum verum) has roughly 1% of the coumarin content — much safer for daily use.
The Mechanism
Cinnamon’s proposed mechanisms include insulin-mimetic activity through hydroxycinnamaldehyde, inhibition of alpha-glucosidase (slowing carbohydrate digestion), and modulation of GLUT4 translocation. Effects are mild, not unlike many polyphenol-rich foods in modest quantities.
Why the Marketing Outpaces the Science
Supplement marketing often cites older trials that showed larger effects (some around 1% HbA1c reduction). Those trials tended to be small, short, and in cohorts with very poor baseline control. When larger, better-designed trials in better-controlled diabetic populations were done, effect sizes shrank.
Practical Position
If you want to use cinnamon, use Ceylon, dose 1–2 g/day with meals, and do not expect pharmaceutical effect. It is not a substitute for glucose-lowering medications or lifestyle changes. It can be a reasonable tea-time ritual with mild benefit. Marketing of "cinnamon + berberine" products generally leans on berberine (which has modest legitimate effects) more than on cinnamon.
Sources
- Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. "Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis." Annals of Family Medicine, 2013;11(5):452–459. PMID 24019277.
- Costello RB, Dwyer JT, Saldanha L, Bailey RL, Merkel J, Wambogo E. "Do cinnamon supplements have a role in glycemic control in type 2 diabetes? A narrative review." Journal of the Academy of Nutrition and Dietetics, 2016;116(11):1794–1802.
- Abraham K, Pütz B, Wahn V, Lampen A. "Toxicology and risk assessment of coumarin: focus on human data." Molecular Nutrition & Food Research, 2010;54(2):228–239.